Physician profile
Krystyna Wesp
NPI 1497103089
$914.47
in general payments reported to CMS, 2019-2025
15 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $50.58 · 2021: $17.05 · 2022: $83.62 · 2023: $94.12 · 2024: $367 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564 · Long Term Medical Supply Or Device Loan: $88.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.35 |
| Long Term Medical Supply Or Device Loan | $88.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $210.10 | 2020-2025 | |
| Cranial Technologies, INC | $162.01 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $89.73 | 2019-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Baxter Healthcare | $88.33 | 2024 | Hillrom - Spot Vision Screener |
| Pfizer INC. | $82.52 | 2019-2025 | |
| Biomarin Pharmaceutical INC. | $52.86 | 2025 | Voxzogo 1.2mg |
| Sobi, INC | $47.76 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $46.94 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $28.10 | 2024 | Flumist Quadrivalent |
| Alk-Abello, INC | $23.40 | 2025 | Neffy, Odactra, Grastek |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.72 | 2019 | |
| Welch Allyn | $17.05 | 2021 | |
| Glaxosmithkline, LLC. | $16.36 | 2019 | |
| Verrica Pharmaceuticals INC. | $15.91 | 2024 | Ycanth |
| Aytu Biopharma, INC. | $14.68 | 2024 | Karbinal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystyna Wesp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.